暂无分享,去创建一个
Daniel L. Rubin | Okyaz Eminaga | Mahmoud Abbas | Christian Kunder | Andreas M. Loening | Yuri Tolkach | Rosalie Nolley | Axel Semjonow | Martin Boegemann | James Brooks | J. Brooks | D. Rubin | R. Nolley | C. Kunder | A. Semjonow | Y. Tolkach | A. Loening | M. Abbas | O. Eminaga | M. Boegemann | Okyaz Eminaga
[1] P. Gumerlock,et al. Human androgen receptor expression in prostate cancer following androgen ablation. , 1997, European urology.
[2] S. Varambally,et al. Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer , 2009, Science.
[3] P. Mahadevan,et al. An overview , 2007, Journal of Biosciences.
[4] A. Nakagawara,et al. Role of p53 in Cell Death and Human Cancers , 2011, Cancers.
[5] Ziding Feng,et al. Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort. , 2009, The Journal of urology.
[6] Hilla Peretz,et al. Ju n 20 03 Schrödinger ’ s Cat : The rules of engagement , 2003 .
[7] J. Tchinda,et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.
[8] Jie Zhang,et al. Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in Cancer , 2009, Cell.
[9] A. Sivachenko,et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer , 2012, Nature Genetics.
[10] W. Isaacs,et al. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. , 2014, The New England journal of medicine.
[11] J. Concato,et al. A simulation study of the number of events per variable in logistic regression analysis. , 1996, Journal of clinical epidemiology.
[12] Jürgen Schmidhuber,et al. Deep learning in neural networks: An overview , 2014, Neural Networks.
[13] Chris Sander,et al. Copy number alteration burden predicts prostate cancer relapse , 2014, Proceedings of the National Academy of Sciences.
[14] R. Rittmaster,et al. Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat. , 1996, The Journal of clinical investigation.
[15] J. Köllermann,et al. Combined histoarchitectural and cytological biopsy grading improves grading accuracy in low‐grade prostate cancer , 2012, International journal of urology : official journal of the Japanese Urological Association.
[16] C S Song,et al. Regulation of androgen action. , 1999, Vitamins and hormones.
[17] M. Rubin,et al. SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling. , 2017, Cancer cell.
[18] D. Gleason. Classification of prostatic carcinomas. , 1966, Cancer chemotherapy reports.
[19] F. Harrell,et al. Regression models for prognostic prediction: advantages, problems, and suggested solutions. , 1985, Cancer treatment reports.
[20] S. Varambally,et al. Therapeutic Targeting of SPINK1-Positive Prostate Cancer , 2011, Science Translational Medicine.
[21] M Soledad Cepeda,et al. Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. , 2003, American journal of epidemiology.
[22] C. Bangma,et al. Disease‐specific death and metastasis do not occur in patients with Gleason score ≤6 at radical prostatectomy , 2015, BJU international.
[23] D. Bostwick,et al. Staging of early prostate cancer: a proposed tumor volume-based prognostic index. , 1993, Urology.
[24] H. Zeng,et al. The association between SPINK1 and clinical outcomes in patients with prostate cancer: a systematic review and meta-analysis , 2017, OncoTargets and therapy.
[25] Rajvir Dahiya,et al. Hormonal, cellular, and molecular control of prostatic development. , 2003, Developmental biology.
[26] N. Kyprianou,et al. Activation of programmed cell death in the rat ventral prostate after castration. , 1988, Endocrinology.
[27] G. Kristiansen,et al. Konsenskonferenz 2014 der ISUP zur Gleason-Graduierung des Prostatakarzinoms , 2016, Der Pathologe.
[28] Guigang Zhang,et al. Deep Learning , 2016, Int. J. Semantic Comput..
[29] Ewout W Steyerberg,et al. Internal and external validation of predictive models: a simulation study of bias and precision in small samples. , 2003, Journal of clinical epidemiology.
[30] H. Zeng,et al. The association between SPINK1 and clinical outcomes in patients with prostate cancer: a systematic review and meta-analysis , 2017, OncoTargets and therapy.
[31] Gleason Df. Classification of prostatic carcinomas. , 1966 .
[32] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[33] Yao-Tseng Chen,et al. Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues , 2007, Modern Pathology.
[34] N. Razavian,et al. Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning , 2018, Nature Medicine.
[35] D. Brat,et al. Predicting cancer outcomes from histology and genomics using convolutional networks , 2017, Proceedings of the National Academy of Sciences.
[36] T. Wheeler,et al. Moving Beyond Gleason Scoring. , 2019, Archives of pathology & laboratory medicine.
[37] B. Delahunt,et al. International Society of Urological Pathology (ISUP) grading of prostate cancer – An ISUP consensus on contemporary grading , 2016, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[38] T. Stamey,et al. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. , 2002, Urology.
[39] Ce Zhang,et al. Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features , 2016, Nature Communications.
[40] A. Uitterlinden,et al. Novel taxonomy-independent deep learning microbiome approach allows for accurate classification of different forensically relevant human epithelial materials. , 2019, Forensic science international. Genetics.
[41] S. Lowe,et al. Tumor suppressive functions of p53. , 2009, Cold Spring Harbor perspectives in biology.
[42] B. Delahunt,et al. [The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma]. , 2016, Der Pathologe.
[43] D. Jäger,et al. Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapy. , 2017, Urologic oncology.
[44] Loris Nanni,et al. Handcrafted vs. non-handcrafted features for computer vision classification , 2017, Pattern Recognit..
[45] P. Pandolfi,et al. SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression. , 2015, Molecular cell.
[46] Andrew J. Schaumberg,et al. D R A F T H&E-stained Whole Slide Image Deep Learning Predicts SPOP Mutation State in Prostate Cancer , 2017 .
[47] Guangtao Zhai,et al. A Deep Learning-Based Radiomics Model for Prediction of Survival in Glioblastoma Multiforme , 2017, Scientific Reports.
[48] J. López-Guerrero,et al. Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer. , 2014, European journal of cancer.
[49] Jun Luo,et al. The mutational landscape of prostate cancer. , 2013, European urology.
[50] B. Trock,et al. SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy Cohort. , 2016, The Journal of urology.
[51] Steven J. M. Jones,et al. The Molecular Taxonomy of Primary Prostate Cancer , 2015, Cell.
[52] Jaya M Satagopan,et al. TMPRSS2–ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features , 2010, Modern Pathology.
[53] Thomas Wiegel,et al. Guidelines on Prostate Cancer , 2013 .
[54] John T. Wei,et al. The role of SPINK1 in ETS rearrangement-negative prostate cancers. , 2008, Cancer cell.
[55] Mahul B Amin,et al. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2017, The American journal of surgical pathology.
[56] D. Tindall,et al. Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance. , 2008, Cancer research.
[57] G. Coetzee,et al. Contribution of the Androgen Receptor to Prostate Cancer Predisposition and Progression , 2004, Cancer and Metastasis Reviews.
[58] L. Egevad,et al. A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. , 2016, European urology.
[59] D. Tindall,et al. Alternatively spliced androgen receptor variants. , 2011, Endocrine-related cancer.
[60] B. Delahunt,et al. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System , 2015, The American journal of surgical pathology.
[61] Ziding Feng,et al. Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort , 2016, The American journal of surgical pathology.
[62] Andrew Zisserman,et al. Very Deep Convolutional Networks for Large-Scale Image Recognition , 2014, ICLR.
[63] C. Heinlein,et al. Androgen receptor (AR) coregulators: an overview. , 2002, Endocrine reviews.